Deep Medicine Acquisition Valuation

Is DMAQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DMAQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate DMAQ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate DMAQ's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DMAQ?

Key metric: As DMAQ is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for DMAQ. This is calculated by dividing DMAQ's market cap by their current book value.
What is DMAQ's PB Ratio?
PB Ratio	-1.7x
Book	-US$7.37m
Market Cap	US$36.56m

DMAQ key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does DMAQ's PB Ratio compare to its peers?

The above table shows the PB ratio for DMAQ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	2.1x
TURN 180 Degree Capital	0.7x	n/a	US$33.2m
GROW U.S. Global Investors	0.7x	n/a	US$33.0m
STEC Santech Holdings	4.9x	n/a	US$30.0m
DMYY dMY Squared Technology Group	n/a	n/a	US$41.7m
DMAQ Deep Medicine Acquisition	n/a	n/a	US$36.6m

Price-To-Book vs Peers: DMAQ has negative equity and a Price-To-Book Ratio (-1.7x) compared to the peer average (0.7x).

Price to Book Ratio vs Industry

How does DMAQ's PB Ratio compare vs other companies in the US Capital Markets Industry?

8 Companies	Price / Book	Estimated Growth	Market Cap
AMTD AMTD IDEA Group	0.06x	n/a	US$78.60m
JPPY.Y Jupai Holdings	0.02x	n/a	US$2.37m
NCPL Netcapital	0.04x	n/a	US$1.43m
LGHL Lion Group Holding	0.04x	n/a	US$1.35m

8 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: DMAQ has negative equity and a Price-To-Book Ratio (-1.7x) compared to the US Capital Markets industry average (-10x).

Price to Book Ratio vs Fair Ratio

What is DMAQ's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DMAQ PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	-1.7x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate DMAQ's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

International Money Express

US$659.3m

Operates as an omnichannel money remittance services company in the United States, Latin America, Mexico, Central and South America, the Caribbean, Africa, and Asia.

IMXI

US$21.32

2.2%

0.09%

VEF

SEK 2.2b

A venture capital firm specializing in early venture, emerging growth and growth capital investments.

VEFF.F

SEK 0.20

n/a

Federal Home Loan Mortgage

US$10.0b

Operates in the secondary mortgage market in the United States.

FMCC

US$3.10

3.3%

384.4%